-
A Randomized Trial Comparing the NeoVas Sirolimus-Eluting Bioresorbable Scaffold and Metallic Everolimus-Eluting StentsYL Han, B Xu, NeoVas Randomized Controlled Trial Investigators -
Overall and Cause-Specific Mortality in Randomized Clinical Trials Comparing Percutaneous Interventions With Coronary Bypass Surgery: A Meta-analysisM Gaudino, I Hameed, ME Farkouh et al.
-
Burden of 30-Day Readmissions After Percutaneous Coronary Intervention in 833,344 Patients in the United States: Predictors, Causes, and CostKwok CS, Rao SV, Potts JE et al.
-
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-upB Bikdeli, MV Madhavan, D Jimenez et al.
-
The spectrum of chronic coronary syndromes: genetics, imaging, and management after PCI and CABGTF Lüscher
-
Qualitative Methodology in Cardiovascular Outcomes Research: A Contemporary LookMcIlvennan CK, Morris MA, Guetterman TC et al.
-
Management of Patients With NSTE-ACS: A Comparison of the Recent AHA/ACC and ESC GuidelinesRodriguez F, Mahaffey KW.
-
2-Year Outcomes After Stenting of Lipid-Rich and Nonrich Coronary PlaquesMHwa Yamamoto, A Maehara, GW Stone et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
